Physician profile
Ellen K Joyner
NPI 1508148768
$1,291.19
in general payments reported to CMS, 2019-2025
14 companies · $126 in 2025
The $126 reported for 2025 was less than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $144 · 2022: $415 · 2023: $194 · 2024: $412 · 2025: $126.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $732.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $732.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $593.49 | 2021-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Abbott Laboratories | $381.92 | 2021-2024 | Nc Trek Neo, Xience Skypoint, Diamondback Coronary |
| Boston Scientific Corporation | $64.33 | 2022-2023 | Watchman Access System |
| Alnylam Pharmaceuticals INC. | $58.76 | 2025 | Amvuttra |
| W. L. Gore & Associates, INC. | $30.84 | 2023 | Gore Cardioform Septal Occluder |
| Amgen INC. | $29.86 | 2023 | Repatha |
| Actelion Pharmaceuticals US, INC. | $21.00 | 2025 | Opsumit, Uptravi |
| Lantheus Medical Imaging, INC. | $19.16 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.68 | 2025 | Trintellix |
| Atricure, INC. | $16.47 | 2024 | |
| Scpharmaceuticals INC. | $15.86 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.61 | 2023 | |
| Chiesi USA, INC. | $14.34 | 2023 | Kengreal, Cleviprex |
| Abiomed | $13.87 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ellen Joyner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.